Clinical Trial

Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Controlled Trial

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated March 3, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to clinically evaluate the efficacy of trigger points using active drug mix (Triamcinolone with lidocaine) on relief of myofascial pain of jaw muscle.
Trial Details
NCT Number NCT07445191
Lead Sponsor Cairo University
Conditions TMJ Pain
Enrollment 30 participants
Start Date 2026-03-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-03